PABLO DEJESUS: Open Payments
NPI 1013176031 · PALM COAST, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$462 in 24 payments from 11 companies in 2025. Trend: 2023 $14 · 2024 $97 · 2025 $462
Food & beverage: $462
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $142 |
| Astellas Pharma US Inc | 2 | $61 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Novo Nordisk Inc | 2 | $32 |
| PFIZER INC. | 2 | $30 |
| ALK-Abello, Inc | 1 | $28 |
| Exact Sciences Corporation | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $18 |
Products named: QULIPTA, Veozah, UBRELVY, TRELEGY ELLIPTA, GEMTESA, NURTEC ODT, Grastek, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
